A part of Merck

GF138 | Insulin-like Growth Factor-I Protein, Recombinant human

GF138
100 µg  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Key ApplicationsSpeciesSourcePurity
      CULT Human E.coli Greater than 98% by SDS-PAGE. Endotoxin level is less than 0.1 ng per μg (1EU/ug) of IGF-1.
      Description
      Catalogue NumberGF138
      ReplacesGF006
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionInsulin-like Growth Factor-I Protein, Recombinant human
      OverviewInsulin Like Growth Factor-I (IGF-I) is a polypeptide growth factor which stimulates the proliferation of a wide range of cell types including muscle, bone, and cartilage tissue. Human IGF-I is a 7.6 kDa protein containing 70 amino acid residues.
      Alternate Names
      • IGF-I
      Background InformationInsulin-like Growth Factor (IGF-1) is a polypeptide endocrine hormone similar in structure to insulin. Stimulated by growth hormone and produced primarily in the liver, it binds to the IGF-1 receptor with a high affinity and to the insulin receptor with a much lower affinity. The tyrosine kinase IGF-1 receptor is a potent activator of the Akt signaling pathway, which drives a variety of processes including cell growth and division and apoptosis inhibition. Because approximately 98% of IGF-1 is always bound to one of six binding proteins (IGF-BP), extraction is required to measure extracellular protein concentrations. Increased levels of IGF-1 have been correlated with an increased risk of cancer. In addition, while involved in reducing hemoglobin A1C levels and daily insulin consumption in types 1 and 2 diabetes, these increased levels have been also implicated in the development of diabetic retinopathy. Drugs have been developed as replacement therapy for severe primary IGF-1 deficiency, a group of diseases in which patients do not respond to growth hormone therapy.
      References
      Product Information
      PresentationLyophilized from sterile filtered 10 mM Sodium Phosphate, pH 6, containing no additives.
      Applications
      ApplicationInsulin Like Growth Factor-I (IGF-I) is a polypeptide growth factor which stimulates the proliferation of a wide range of cell types including muscle, bone & cartilage tissue.
      Key Applications
      • Cell Culture
      Application NotesFor most in vitro applications, IGF-I exerts its biological activity in the concentration range of 0.2 to 20.0 ng/mL. Responding cells are (partial list): bone, muscle cells, CHO cells.

      Optimal working dilutions must be determined by end user.
      Biological Information
      PurityGreater than 98% by SDS-PAGE. Endotoxin level is less than 0.1 ng per μg (1EU/ug) of IGF-1.
      SourceE.coli
      Specific ActivityHuman IGF-I is fully biologically active when compared to standards. The ED50 as determined by a cell proliferation assay using FDC-P1 cells is <=10.0 ng/mL corresponding to a specific activity of >=1 x 10e5 units/mg.
      Entrez Gene Number
      Gene Symbol
      • IGF1
      • Somatomedin-C
      • IGF-IB
      • IGF-IA
      • IBP1
      • MGF
      • IGFI
      UniProt Number
      Stem Cell Type
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsThe lyophilized IGF-I, though stable at room temperature, is best stored at -20°C for up to 12 months from date of receipt. After a quick spin, reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL. This solution can be diluted into other buffered solutions and stored at 4°C for one week or at -20°C for future use. Reconstituted IGF-I should be stored in undiluted aliquots at -20°C for up to six months. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Certificados de análisis

      CargoNúmero de lote
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I - 2211021 2211021
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I -2500478 2500478
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I -2700964 2700964

      Ficha técnica

      Cargo
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I
      RECOMBINANT HUMAN INSULIN LIKE GROWTH FACTOR-I
      Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

      Productos y aplicaciones relacionados

      Familias de productos

      Categorías

      Life Science Research > Proteins and Enzymes > Cytokines & Growth Factors
      Life Science Research > Cell Culture and Systems > Cell Culture Media and Supplements > Cell Culture Supplements > Cytokines & Growth Factors